search
Back to results

An Exploratory Investigation of a Novel Skincare Regimen

Primary Purpose

Wrinkle, Photoaging, Acne

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Aria Trio complete Facial System
Sponsored by
Trophy Skin
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Wrinkle focused on measuring wrinkles, fine lines, photoaging, sun spots, acne, enlarged pores, skin health

Eligibility Criteria

25 Years - 65 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Must experience early-stage wrinkles that are not treated by topical or oral prescription drugs/medication
  • Must experience early-stage wrinkles that are not treated by over the counter products (e.g. Adapalene/Differin)
  • May experience hyperpigmentation and/or dark spots
  • In good general health
  • Willing to follow the study protocol skincare routine
  • Willing and able to share feedback and take skin pictures via the technology portal
  • Discontinue use of any alpha-hydroxy acids (AHAs) or over the counter exfoliating, polishing, or peeling topical skincare treatments 1 week before and for the duration of the study.

Exclusion Criteria:

  • Anyone with a diagnosed skin condition on their face
  • Use of prescription medication relevant to the skin
  • Undergoing any cosmetic procedures during the study including Botox, laser, or chemical peel treatments
  • Use of oral acne treatment (e.g., Accutane)
  • Severe chronic conditions, including oncological conditions or psychiatric disorders.
  • Is pregnant, attempting pregnancy, or breastfeeding

Sites / Locations

  • Citruslabs

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Aria Trio complete Facial System

Arm Description

Skincare system targetting wrinkles, pore size, sun spots, and overall skin quality.

Outcomes

Primary Outcome Measures

To assess the effectiveness of the Aria Trio Complete Facial System in being able to reduce blemishes, lines, and wrinkles.
Blemishes, lines, and wrinkles will be examined using photos taken by the participants at three timepoints during the study.

Secondary Outcome Measures

To determine the effectiveness of the Aria Trio Complete Facial System being able to improve perceptions of wrinkles, pore size, sun spots, and overall skin quality
Participants will be given surveys at three timepoints so that they can assess the effectiveness of the product over the 4-week trial period

Full Information

First Posted
August 24, 2022
Last Updated
August 24, 2022
Sponsor
Trophy Skin
Collaborators
Citruslabs
search

1. Study Identification

Unique Protocol Identification Number
NCT05517720
Brief Title
An Exploratory Investigation of a Novel Skincare Regimen
Official Title
An Exploratory Investigation of a Novel Skincare Regimen
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
April 13, 2022 (Actual)
Primary Completion Date
July 1, 2022 (Actual)
Study Completion Date
July 1, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Trophy Skin
Collaborators
Citruslabs

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
This trial will assess the effectiveness of the Aria Trio Complete Facial system in being able to reduce blemishes, lines, and wrinkles. This skincare system that has three different functions in association with three unique serums. It is hypothesized that this customized skincare system will improve skin quality, reduce wrinkles, and reduce other skin related issues.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wrinkle, Photoaging, Acne, Skin Inflammation
Keywords
wrinkles, fine lines, photoaging, sun spots, acne, enlarged pores, skin health

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
38 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Aria Trio complete Facial System
Arm Type
Experimental
Arm Description
Skincare system targetting wrinkles, pore size, sun spots, and overall skin quality.
Intervention Type
Other
Intervention Name(s)
Aria Trio complete Facial System
Intervention Description
Renew Serum, Brighten Serum, and Refine Serum.
Primary Outcome Measure Information:
Title
To assess the effectiveness of the Aria Trio Complete Facial System in being able to reduce blemishes, lines, and wrinkles.
Description
Blemishes, lines, and wrinkles will be examined using photos taken by the participants at three timepoints during the study.
Time Frame
4 weeks
Secondary Outcome Measure Information:
Title
To determine the effectiveness of the Aria Trio Complete Facial System being able to improve perceptions of wrinkles, pore size, sun spots, and overall skin quality
Description
Participants will be given surveys at three timepoints so that they can assess the effectiveness of the product over the 4-week trial period
Time Frame
4 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Must experience early-stage wrinkles that are not treated by topical or oral prescription drugs/medication Must experience early-stage wrinkles that are not treated by over the counter products (e.g. Adapalene/Differin) May experience hyperpigmentation and/or dark spots In good general health Willing to follow the study protocol skincare routine Willing and able to share feedback and take skin pictures via the technology portal Discontinue use of any alpha-hydroxy acids (AHAs) or over the counter exfoliating, polishing, or peeling topical skincare treatments 1 week before and for the duration of the study. Exclusion Criteria: Anyone with a diagnosed skin condition on their face Use of prescription medication relevant to the skin Undergoing any cosmetic procedures during the study including Botox, laser, or chemical peel treatments Use of oral acne treatment (e.g., Accutane) Severe chronic conditions, including oncological conditions or psychiatric disorders. Is pregnant, attempting pregnancy, or breastfeeding
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christopher Hill, PhD
Organizational Affiliation
Citruslabs
Official's Role
Principal Investigator
Facility Information:
Facility Name
Citruslabs
City
Santa Monica
State/Province
California
ZIP/Postal Code
90404
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

An Exploratory Investigation of a Novel Skincare Regimen

We'll reach out to this number within 24 hrs